Theta burst stimulation in the treatment of chronic orofacial pain: a randomized controlled trial
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, randomizované kontrolované studie
PubMed
28937248
DOI
10.33549/physiolres.933474
PII: 933474
Knihovny.cz E-zdroje
- MeSH
- časové faktory MeSH
- chronická bolest diagnóza patofyziologie terapie MeSH
- dospělí MeSH
- dvojitá slepá metoda MeSH
- hmatová percepce MeSH
- lidé středního věku MeSH
- lidé MeSH
- měření bolesti MeSH
- mozek patofyziologie MeSH
- obličejová bolest diagnóza patofyziologie terapie MeSH
- percepce bolesti MeSH
- práh bolesti MeSH
- prospektivní studie MeSH
- senioři MeSH
- transkraniální magnetická stimulace škodlivé účinky metody MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
- Geografické názvy
- Česká republika MeSH
Theta burst stimulation (TBS) is a modified form of high-frequency repetitive transcranial magnetic stimulation (rTMS) with promising effect in chronic pain. The aim of our double-blind, sham-controlled, parallel-group, randomized study was to assess an efficacy of intermittent TBS (iTBS) in the treatment of patients with chronic orofacial pain. Nineteen patients (twelve females) with chronic orofacial pain were prospectively included and randomly assigned to single session of an active (iTBS) or sham (intermediate TBS; imTBS) stimulation delivered to the primary motor cortex (M1) contralateral to painful side. The primary outcome was pain relief assessed using a visual analogue scale (VAS) after stimulation and at the end of two-week follow- up. The secondary outcomes were changes in the quantitative sensory testing (QST). QST set the threshold for thermal and tactile (touch) sensation in the affected facial area. Intermittent TBS, compared with the sham, showed significant improvement in VAS after stimulation, but not at the end of two-week follow-up. Regarding the secondary outcomes (QST), we failed to find any significant difference between iTBS and sham. Our findings demonstrate that iTBS of M1 transiently provides transient and modest subjective pain relief in chronic orofacial pain.
Citace poskytuje Crossref.org
Phosphene Attributes Depend on Frequency and Intensity of Retinal tACS